Home | Staff Directory

Thomas Lee

Thomas Lee

Reporter  |  Emerging and Growth Companies

Phone: 612-673-7744

E-mail: tlee@startribune.com

Thomas Lee covers Minnesota’s emerging companies, primarily in the medical and technology industries.

Recent content from Thomas Lee

  • Danish drugmaker closing Brooklyn Park facility
    Danish drugmaker Genmab is closing its Brooklyn Park plant as part of money-saving efforts, putting 130 people out of work.
    Nov 6, 2009
  • Minnesota start-up has got BarK IN ITS BITE
    Bite Tech says it has mouth guards that can improve strength and reduce fatigue. And athletes are buying into it.
    Nov 6, 2009
  • Project: Honing the Edge
    A continuing series on innovation in Minnesota.
    Nov 1, 2009
  • Nanotechnology: A risky frontier?
    Nanotechnology already has found hundreds of high-tech uses. But do its tiny particles pose big health risks? That uncertainty, and companies' reluctance to embrace the field, cloud its future.
    Nov 1, 2009
  • Mergers, acquisitions: Slow, with signs of life
    Despite an uptick in stock offerings, investment banks with strong ties to Minnesota advised a paltry 29 mergers and acquisitions in the third quarter, only two more than the previous three months, according to the Star Tribune Quarterly Deals Report.
    Oct 25, 2009
  • Venture investors shy away from state firms
    Total quarterly venture-capital investments totaled only $26.4 million, Minnesota's worst showing since 1995.
    Oct 19, 2009
  • Data mining 2.0
    A promising start-up offers online marketers new ways to collect and analyze up-to-date information.
    Oct 11, 2009
  • St. Jude stock slides on profit warning
    But Wall Street really is wondering whether St. Jude's alert is a symptom of industry-wide trouble to come.
    Oct 6, 2009
  • Badger State's tech boom
    Part 2: A look under the hood at Wisconsin's biotech start-up machine reveals a powerfully successful combination of academic and commercial cooperation.
    Oct 1, 2009
  • A bio border battle
    Part 1: Wisconsin has biotechnology investment down to a science, bounding ahead of Minnesota with a broad, tax-friendly strategy. Coming tomorrow, part 2: Badger State's tech boom.
    Sep 30, 2009